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Oculodentodigital dysplasia (ODDD) is a rare genetic disorder associated with a characteristic craniofacial profile with variable dental,
limb, eye, and ocular adnexa abnormalities. We performed an extensive literature review to highlight key eye features in patients with
ODDD and report a new case of a female patient with a heterozygous missense GJA1 mutation (c.65G>A, p.G22E) and clinical
features consistent with the condition. Our patient presented with multiple congenital anomalies including syndactyly,
microphthalmia, microcornea, retrognathia, and a small nose with hypoplastic alae and prominent columella; in addition, an
omphalocele defect was present, which has not been reported in previous cases. A systematic review of the published cases to date
revealed 91 literature reports of 295 individuals with ODDD. There were 73 different GJA1 mutations associated with these cases,
of which the most common were the following missense mutations: c.605G>A (p.R202H) (11%), c.389T>C (p.I130T) (10%), and
c.119C>T (p.A40V) (10%). Mutations most commonly affect the extracellular-1 and cytoplasmic-1 domains of connexin-43 (gene
product of GJA1), predominately manifesting in microphthalmia and microcornea. The syndrome appears with an approximately
equal sex ratio. The most common eye features reported among all mutations were microcornea, microphthalmia, short palpebral
fissures, and glaucoma.
1. Introduction
Oculodentodigital dysplasia (ODDD, OMIM #164200) is a
rare disorder mainly characterized by abnormal craniofacial,
dental, ocular, and digital development. The autosomal
dominant form has been the most frequently reported inher-
itance pattern, although a few cases of autosomal recessive
inheritance have been described [1–3]. Craniofacial abnor-
malities may include microcephaly, prominent columella,
and underdeveloped nasal alae [2–4]. Dental abnormalities,
such as hypoplastic enamel, small teeth, and premature loss
of teeth, are often present [2–4]. Digit abnormalities may
include syndactyly, camptodactyly, and midphalangeal
hypoplasia [2–4]. Ophthalmic manifestations are common,
such as microcornea and microphthalmia, and may involve
a wide spectrum of eye and ocular adnexa structures,
although previous analyses of prior cases show that full ocu-
lar physical exams were not performed on all patients [3, 5].
The gap junction protein alpha 1 (GJA1) gene codes for
connexin-43, which is a protein that assists in the trans-
membrane transport of molecules through gap junctions,
and mutations in the GJA1 may cause an alteration of the
channel conduction properties [1–3, 6]. We report a case
of an 8-month-old female patient with an identified GJA1
mutation and common clinical features associated with
ODDD. This patient had an omphalocele at birth, which
has not been reported in previous cases. Her eye features
included microphthalmia, microcornea, narrow palpebral
fissures, blonde fundus, deep anterior chambers, hyperopia,
and epiphora in both eyes secondary to bilateral nasolacrimal
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duct obstructions. We conducted an extensive literature
review to summarize the eye features in patients with ODDD
reported to date.
2. Case Report
The patient, an 8-month-old female, was born to a noncon-
sanguineous couple from a healthy 37-year-old mother of
Native American descent and a healthy 30-year-old father
of German and Irish descent. Family history is notable for
an older sibling with cleft palate, paternal uncle with autism,
paternal second cousin with congenital heart defect, and dis-
tant paternal great-great uncle with Down syndrome and
webbed/fused 4th and 5th digits of one hand. A normal preg-
nancy was noted until the second trimester when an ompha-
locele was detected on ultrasound. A subsequent ultrasound
revealed possible syndactyly of the hands. The patient was
born at 39 weeks by vaginal delivery with induction. The
birth weight was 3.552 kg (75th percentile), birth length was
50 cm (68th percentile), and birth head circumference was
34.5 cm (70th percentile). Apgar scores were 9 at both one
minute and five minutes.
Multiple congenital anomalies noted at birth included an
omphalocele that measured 4 cm at base and 3.5 cm across
with intestines present in the sac, but no liver. The patient
had a normocephalic head with sparse wispy hair, a small
nose with hypoplastic alae, a prominent columella, small-
appearing palpebral fissures, a small cornea, microphthalmia,
a wide anterior fontanelle, and retrognathia (Figure 1). Syn-
dactyly of digits 4 and 5 and webbing of digits 3 and 4 of
the right (Figure 2) and left hands were present. Cardiac
echocardiogram on the day of birth showed the presence of
a mild patent ductus arteriosus, mild patent foramen ovale,
and a normal aorta. Feeding difficulties were exacerbated by
the presence of the omphalocele; surgical correction was per-
formed on day 2 of life.
An ophthalmologic assessment at 4 months of age was
notable for deep anterior chambers, bilateral nasolacrimal
duct obstruction, microphthalmia, small 8mm corneas, a
blonde fundus, and moderate hyperopia in both eyes.
At her last examination at 8 months of age, the patient
continues to have poor feeding with self-limiting volumes
but has improved weight gain. The patient is at the 9th per-
centile for weight and 12th percentile for length. Cognitive
and motor developments are delayed.
Sequencing of the GJA1 gene (transcript number: NM_
000165.3) from patient genomic DNA revealed a heterozygous
missense mutation in the GJA1 gene: c.65G>A (p.G22E).
Deletion/duplication analysis of the GJA1 gene using the
aCGH test was negative.
3. Methods
We performed a systematic review of the literature to sum-
marize the ocular findings in individuals with ODDD. A
PubMed/Medline search of “oculodentodigital syndrome”
led us to find a total of 177 articles. No articles were excluded
based on the year published. We reviewed the references to
identify other articles that did not appear in our original
search. 91 articles describing patients with a description con-
sistent with the clinical syndrome, either with or without
molecular confirmation of GJA1 pathogenic variants, were
included. Within these selected articles, we identified 295
cases of ODDD with 73 different GJA1 mutations, including
Figure 1: Facial photograph of a patient with oculodentodigital
dysplasia; note the beaked nose with hypoplastic alae and
prominent columella, microphthalmia, microcornea, small
palpebral fissures, retrognathia.
Figure 2: Complete syndactyly of the 4th and 5th digits of the right
hand.
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those that exhibited features of ODDD in the absence of
molecular confirmation. Such individuals were either clini-
cally diagnosed or were relatives of individuals with molecu-
larly confirmed GJA1 pathogenic variants. Twelve reported
that GJA1 gene coding alterations were omitted due to insuf-
ficient clinical information and data reported and are listed in
Table 1 [3, 6].
4. Discussion
Oculodentodigital dysplasia (ODDD) is a rare congenital dis-
order manifested with developmental anomalies of the eyes,
face, dentition, heart, skeletal system, and digits. The syn-
drome appears to be more common in Caucasian popula-
tions with an equal sex ratio [3]. Heterozygous mutation of
the GJA1 gene located at chromosome 6q22.31 has been
identified as the most common mutation resulting in ODDD
[2, 3]. However, a compound heterozygous individual with
missense mutations demonstrated mutations in the GJA1
gene (p.V41L) and the GJB2 gene (p.R127H), which encode
for connexin-43 and connexin-26, respectively, and has been
reported and classified as having overlapping features of
Clouston syndrome and ODDD [3, 7].
In addition to the classic phenotypic features of the syn-
drome, a wide variety of additional physical manifestations
have been observed. Ocular findings of microphthalmia and
microcornea have been observed commonly in previous
cases [2–4]. Craniofacial anomalies of microcephaly, poor
hair growth, hypoplastic nasal alae, and prominent columella
have been reported previously [2–4]. Bilateral syndactyly of
the 4th and 5th digits is common [2, 3].
A systematic review of the published cases to date
(ranging from 1963 to 2019) revealed 91 literature reports
of 295 individuals with ODDD [1–91]. Table 2 [1–91] sum-
marizes the sex distribution across all reviewed reports of
ODDD. Patients with ODDD present with an approxi-
mately equal sex distribution (47% male and 53% female).
Of the 295 individuals reported, 32 were clinically diag-
nosed with ODDD without molecular confirmation, 98 pre-
sented with features of ODDD and had a known relative
with molecular confirmation of a GJA1 pathogenic variant,
and 165 individuals had a molecularly confirmed GJA1
pathogenic variant.
There were 73 different GJA1 mutations identified from
the 165 individuals that had a molecularly confirmed GJA1
pathogenic variant. Table 3 [1–3, 5–71, 92] summarizes the
number of patients with each mutation. Patients with con-
firmed pathogenic variants and their relatives with no molec-
ular confirmation but with features of ODDD were grouped
separately. These two groups comprised 263 of the patients
included in this study.
The eye features of all 295 patients are summarized in
Table 4 [1–91]. The most common ophthalmic manifesta-
tions reported were microcornea (n = 111), microphthalmia
(n = 110), short palpebral fissures (n = 56), and glaucoma
(n = 51, 4 closed-angle and 1 open-angle).
Twenty-three patients presented with refractive error, of
which isolated myopia was the most frequently noted
(n = 14), followed by isolated hyperopia (n = 6), anisometro-
pia (n = 2), and astigmatism (n = 1). Forty patients presented
with eye movement disorders, with strabismus (n = 27, 9 eso-
tropic, 1 exotropic) being the most common, followed by
nystagmus (n = 8), amblyopia (n = 3), Duane syndrome
(n = 2), and Brown syndrome (n = 1). Note that 1 patient
had both nystagmus and esotropia [71]. Other common find-
ings included epicanthus (n = 36), hypotelorism (n = 24),
hypertelorism (n = 22), madarosis (n = 19), cataracts (n = 17),
persistent pupillary membranes (n = 13), shallow anterior
chambers (n = 12), pale/atrophic irides (n = 11), telecanthus
(n = 11), and uveitis (n = 10).
A variety of abnormal findings for the retina and optic
disc were noted (n = 18), with dysplasia of the retina/fundus
(n = 3) and pale/atrophic optic discs (n = 3) being the most
common documented findings.
Of the individuals with molecularly confirmed muta-
tions, the most common mutations present were c.605G>A
(p.R202H) (11%; with 1 patient also having a c.717G>A
synonymous mutation), c.389T>C (p.I130T) (10%), and
c.119C>T (p.A40V) (10%). Table 5 [2, 3, 12, 30, 40, 41, 66,
67, 92] summarizes the eye features present in the patients
with these mutations.
Less common features of the phenotype observed in our
presented case were also reported in other cases as well. These
include nasolacrimal duct abnormalities (n = 2), pale/atrophic





Paznekas et al. [3] c.7G>A p.D3N 1
Paznekas et al. [3] c.64G>A p.G22R 1
Paznekas et al. [3];
Richardson et al. [6]
c.79T>C p.S27P 1
Paznekas et al. [3] c.163A>G p.N55D 1
Paznekas et al. [3] c.174A>C p.Q58H 1
Paznekas et al. [3] c.175C>G p.P59A 1
Paznekas et al. [3] c.221A>T p.H74L 1
Paznekas et al. [3] c.428G>A p.G143D 1
Paznekas et al. [3] c.430A>G p.K144E 1
Paznekas et al. [3] c.434T>G p.V145G 1
Paznekas et al. [3] c.442C>G p.R148G 1
Paznekas et al. [3] c.578C>T p.P193L 1
Table 2: Summary of sex distribution.
Males Females Total
Individuals with clinical diagnosis
of ODDD (with no molecular
confirmation)
14 45% 18 56% 32
Untested individuals with both
ODDD phenotype and known
relative with molecular confirmation
52 53% 46 47% 98
Individuals with a molecular
confirmed GJA1 pathogenic variant
72 44% 93 56% 165
Totals 138 47% 157 53% 295





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































9Case Reports in Ophthalmological Medicine
retina/fundus (n = 2), and deep anterior chambers (n = 2).
Additionally, including this study, the three patients with
the p.G22E mutation have the following findings: micro-
phthalmia (n = 3), cataracts (n = 1), microcornea (n = 2),
blonde fundus (n = 1), persistent pupillary membrane
(n = 1), deep anterior chamber (n = 1), hyperopia (n = 1),
strabismus (n = 2, 1 esotropic), amblyopia (n = 1), glaucoma
(n = 1), short palpebral fissures (n = 1), nasolacrimal duct
abnormalities (n = 1), and epicanthus (n = 1) [2, 3, 21, 22].
Some unique genotype-phenotype correlations were noted
upon further analysis. Three patients presented with eccentric
pupils, but only 2 of these patients were reported with an asso-
ciated mutation. Both mutations (p.Q49dup and p.Q49P)
seem to affect the same amino acid in connexin-43 [3, 61,
72]. Additionally, uveitis was reported in 10 patients, 9 of
which were associated with similar mutations. Eight of these
patients were within the same study and had the p.H194P
mutation, another patient had no molecular confirmation
of a GJA1 mutation, and the other patient was reported with
a missense mutation on exon 2 [4, 9, 10, 27, 28]. However,
since the majority of these patients were reported within
the same study, the apparent genotype-phenotype correla-
tion of p.H194P and uveitis might be due to underreporting
of uveitis from other sources with different pathogenic vari-
ants or may be due to other factors of the family not identi-
fied within the study.
Further analysis of the genotype-phenotype correlation
was conducted by pairing the phenotypic manifestations
of each mutation with the corresponding defects in the
connexin-43 domains. The domains were defined by the
amino acid ranges provided on UniProt (P17302–CXA1_
HUMAN) [93]. Table 6 [1–3, 5–71, 92, 93] provides a sum-
mary of the phenotypes associated with mutations from
each domain.
The domains most commonly affected by GJA1 muta-
tions are the extracellular-1 loop and the cytoplasmic-1 loop
of connexin-43, accounting for 19 and 20 mutations,
respectively. Disruptions in the extracellular-1 loop pre-
sented primarily as microphthalmia (n = 32) and micro-
cornea (n = 30). A similar pattern can be seen in the
cytoplasmic-1 loop, as the most common presentations were
microphthalmia (n = 20) and microcornea (n = 18). Other
clinical findings, however, may be able to distinguish muta-
tions resulting from these domains. The next most common
findings associated with mutations in the extracellular-1 loop
were glaucoma (n = 15) and hypertelorism (n = 11), as
opposed to short palpebral fissures (n = 14) and hypotelor-
ism (n = 14) for the cytoplasmic-1 loop.
Mutations affecting the cytoplasmic N-terminus and the
transmembrane-1 domain shared similar features to the
ones in the extracellular-1 and cytoplasmic-1 domains, as
microphthalmia and microcornea were the most common
clinical findings. However, the mutations in the cytoplas-
mic N-terminus and transmembrane-1 domain presented
with microcornea (n = 17 and n = 21, respectively) more
frequently than microphthalmia (n = 5 and n = 14, respec-
tively). The opposite pattern is true for the extracellular-1
and cytoplasmic-1 domains.
The mutations in the extracellular-2 loop demonstrate a
different phenotypic pattern, as microphthalmia (n = 14)
occurs the most frequently, while microcornea is less fre-
quent (n = 4). Mutations in the transmembrane-2 domain
also display a unique pattern, with hypertelorism (n = 5)
being the most frequent clinical finding. Other domains
listed in Table 6 also demonstrate some unique clinical pat-
terns, but this may be due to variability from the small num-
ber of samples. The patterns mentioned previously, however,
still provide insight into the role of different connexin-43

















Paznekas et al. 2009;
Paznekas et al. 2003
No c.605G>A p.R202H 17 Microphthalmia (1),
microcornea (2)
Nishat et al. 2012;
Paznekas et al. 2009;
Paznekas et al. 2003; and
Amador et al. 2008
No c.389T>C p.I130T 17
Microphthalmia (4),
hypotelorism (6), cataract (1),
pale/atrophic optic disc (1),
and short palpebral fissures (4)
Park et al. 2019;
Hayashi et al. 2014;
Paznekas et al. 2009;
Debeer et al. 2005; and
Paznekas et al. 2003
No c.119C>T p.A40V 17
Microphthalmia (9), hypertelorism (3),
hypotelorism (4), short axial length (4),
cataract (1), microcornea (8),
thick cornea (4), macular
hypoplasia (1), shallow anterior
chamber (4), myopia (4),
strabismus (6) (1 esotropic),
glaucoma (6), and epicanthus (3)
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Microcornea (7), microphthalmia (5), epicanthus (4),
strabismus (3) (1 esotropic), short palpebral fissures (2),
telecanthus (2), amblyopia (1), dysplastic fundus (1),
optociliary vein (1), dysplastic optic disc (1), pale/atrophic
optic disc (1), persistent pupillary membrane (1), myopia (3),
hyperopia (1) (anisometropic), glaucoma (1), ptosis (1),












Microcornea (21), microphthalmia (14), short palpebral
fissures (11), persistent pupillary membrane (6),
madarosis (6), epicanthus (6), glaucoma (5), anterior
iris stroma hypoplasia (3), hypertelorism (2), cataract (2),
iris abnormalities (2), blonde fundus (1), iridoschisis (1),
deep anterior chamber (1), hyperopia (2), strabismus (7)
(3 esotropic), amblyopia (1), nystagmus (1), ptosis (1),
epiblepharon (1), nasolacrimal duct obstruction (1), and























Microphthalmia (32), microcornea (30), glaucoma (15)
(2 closed-angle, 1 open-angle), hypertelorism (11),
epicanthus (10), strabismus (9) (3 esotropic), short
palpebral fissures (9), iris atrophy (peripupillary) (8),
cataract (6), shallow anterior chamber (6), hypotelorism (5),
short axial length (4), myopia (4), corneal farinata (4),
telecanthus (3), iris abnormalities (2), eccentric pupils (2),
persistent pupillary membrane (2), dysplastic fundus (1),
dysplastic optic (1), macular hypoplasia (1), synechiae (1),
ciliary body cysts (1), deep anterior chamber (1),
hyperopia (1), ptosis (1), blepharophimosis (1), madarosis (1),











Hypertelorism (5), microcornea (2), microphthalmia (3),
glaucoma (3), strabismus (2) (1 esotropic), short palpebral
fissures (2), eyelid mucosal hypertrophy (1), telecanthus (1),
epicanthus (1), optic disc atrophy (1), hyperopia (1), myopia (1),
strabismus (1), paracentral scotoma (1), madarosis (1), and
delayed visual evoked potentials (1)
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domains in providing phenotypic variability among patients
with ODDD.
In conclusion, this report provides a comprehensive
review of the eye and ocular adnexa abnormalities that are
currently known to be associated with the ODDD phenotype.
Limitations of this report include the possibility of an incom-
plete ophthalmologic evaluation and/or lack of reporting of
eye features in all of the evaluated case reports or misdiagno-
sis in the individuals with the ODDD phenotype without
molecular confirmation. As such, it is possible that the
reported common eye features within this summary may be
over or underrepresented. Ophthalmic manifestations are
commonly associated within the phenotype, and a wide spec-
trum of eye and ocular adnexa structures may be affected.
The rarity of this condition provides further incentive to fur-
ther investigate the phenotype.
Consent






























Microphthalmia (20), microcornea (18), short palpebral
fissures (14), hypotelorism (14), glaucoma (9), myopia (7),
epicanthus (5), cataract (3), strabismus (3), shallow anterior
chamber (3), hypertelorism (2), opaque lens (1), optic disc
hypervascularity (1), pale/atrophic optic disc (1), pale
irides (1), iris abnormalities (2), astigmatism (1), Duane
syndrome (1), ptosis (1), occipital subcortical white matter












Microphthalmia (18), uveitis (8), glaucoma (8),
microcornea (4), opaque cornea (2), thick choroid (2),






Microphthalmia (1), glaucoma (1), microcornea (1), and













Short palpebral fissures (3), epicanthus (2), hypotelorism (2),
microcornea (2), pale irides (2), myopia (2), hyperopia (1)
(1 anisometropic), corneal opacity (1), microphthalmia (1),
retinal dysplasia (1), choroid thinning (1), glaucoma (1),




Microphthalmia (1), cataract (1), microcornea (1), uveitis (1),
glaucoma (1), epicanthus (1), telecanthus (1), short palpebral
fissures (1), and ptosis (1)
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